Mallinckrodt and Endo, pharmaceutical companies that have each encountered business struggles, announced Thursday a $6.7 billion merger that they contend will result in a combined entity with the ...

Another opioid maker has decided to pursue bankruptcy in the face of mounting litigation. Endo has filed for chapter 11 protection in New York, the Dublin-based company said Tuesday. The decision ...